In several RCTs, GLP-1RAs, when used alone or in combination with other hypoglycemic agents including metformin, sulfonylurea, DPP-4 inhibitor, thiazolidinedione, and sodium-glucose cotransporter 2 inhibitor, showed superior or non-inferior blood glucose lowering ability compared to insulin treatment [64,65]
GLP-1 medications improve blood-sugar handling while we address the underlying resistance so results hold
1 GHK-Cu Copper Peptide Powder
Mechanistic analyses reveal glucagon receptor activation plays a crucial role through increased hepatic fatty acid oxidation and reduced de novo lipogenesis
EGCG (a catechin from green tea) prevents A aggregation, reduces plaque toxicity, and enhances synaptic plasticity while providing strong antioxidant effects (Valeri and Mazzon, 2021)
This helps raise and sustain energy levels, providing long-lasting power for your active lifestyle, workouts, and recovery